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Obesity, a risk factor for the development of type-2 diabetes, hypertension, cardiovascular 19 
disease, hepatic steatosis and some cancers, has been ranked in the top 10 health risk in the 20 
world by the World Health Organization. Despite the growing body of literature evidencing 21 
an association between the obesity epidemic and specific chemical exposure across a wide 22 
range of animal taxa, very few studies assessed the effects of chemical mixtures and 23 
environmental samples on lipid homeostasis. Additionally, the mode of action of several 24 
chemicals reported to alter lipid homeostasis is still poorly understood. Aiming to fill some 25 
of these gaps, we combined an in vivo assay with the model species zebrafish (Danio rerio) 26 
to screen lipid accumulation and evaluate expression changes of key genes involved in lipid 27 
homeostasis, alongside with an in vitro transactivation assay using human and zebrafish 28 
nuclear receptors, retinoid X receptor α and peroxisome proliferator-activated receptor γ. 29 
Zebrafish larvae were exposed from 4 day post-fertilization until the end of the experiment 30 
(day 18), to six different treatments: experimental control, solvent control, tributyltin at 100 31 
ng/L Sn and 200 ng/L Sn (positive control), and wastewater treatment plant influent at 32 
1.25% and 2.5%. Exposure to tributyltin and to 2.5% influent led to a significant 33 
accumulation of lipids, with white adipose tissue deposits concentrating in the perivisceral 34 
area. The highest in vitro tested influent concentration (10%) was able to significantly 35 
transactivate the human heterodimer PPARγ/RXRα, thus suggesting the presence in the 36 
influent of HsPPARγ/RXRα agonists. 37 
Our results demonstrate, for the first time, the ability of complex environmental samples 38 
from a municipal waste water treatment plant influent to induce lipid accumulation in 39 
zebrafish larvae.  40 
Keywords: obesity, obesogen, endocrine disruptor, environmental mixture, nuclear 41 
receptor. 42 
1. INTRODUCTION 43 
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Obesity, the result of a prolonged disturbance of energy homeostasis favoring triglyceride 44 
storage and adipocyte hypertrophy, has been reported to be reaching epidemic proportions, 45 
affecting developed and developing countries and increasing prevalence among children 46 
and animals (Chamorro-García and Blumberg, 2014; Grün and Blumberg, 2009; Landgraf 47 
et al., 2017; Newbold et al., 2007; Minchin & Rawls, 2011; Santos et al., 2012). In addition 48 
of being a risk factor for type-2 diabetes, hypertension, cardiovascular disease, hepatic 49 
steatosis, premature mortality and some cancers, among other medical conditions (Grün and 50 
Blumberg, 2009; Landgraf et al., 2017; Minchin and Rawls, 2011; Newbold et al., 2007), 51 
obesity has a detrimental impact on economic development costing billions of dollars 52 
annually in direct or indirect care (Spencer & Tilbrook, 2011). Consequently, it is ranked in 53 
the top 10 health risks in the world by the World Health Organization, with the number of 54 
overweight people exceeding the number of undernourished ones worldwide (Newbold et 55 
al., 2007). 56 
An increasing body of evidence suggest that this condition does not develop solely from a 57 
chronic positive energy balance (high caloric intake versus lack of exercise), but is rather a 58 
consequence of complex interactions between genetic and environmental factors (Bašić et 59 
al., 2012; Capitão et al., 2017; Chamorro-García and Blumberg, 2014; Dimastrogiovanni et 60 
al., 2015; Grün and Blumberg, 2009; Lyssimachou et al., 2015; Minchin and Rawls, 2011; 61 
Newbold et al., 2007; Santos et al., 2012; Spencer and Tilbrook, 2011). The disruption of 62 
energy homeostasis by endocrine disrupting chemicals (EDCs) is an emerging new field 63 
and could explain the rapid increase in obesity rates observed in animals living in close 64 
proximity to human populations in industrialized societies (Chamorro-García and 65 
Blumberg, 2014; Grün and Blumberg, 2009; Klimentidis et al., 2011; Lyssimachou et al., 66 
2015; Newbold et al., 2007), which coincided with the massive release of industrial 67 
chemicals over the past decades (Newbold et al., 2007; Santos et al., 2012). 68 
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Lipid homeostasis is controlled by complex networks and feedback mechanisms involving 69 
several body organs, transcription factors (e.g. nuclear receptors (NR)), enzymes, hormones 70 
and nutrients, with a complex cross-talk between different signaling pathways (Capitão et 71 
al., 2017, 2018; Moseti et al., 2016). The central nervous system is the coordinator of all 72 
these processes, acting as a lipid and hormone sensor and integrating and transforming 73 
afferent information from other organs into signals that will ensure necessary adjustments, 74 
for example, by changing feeding behavior or energy expenditure (Lyssimachou et al., 75 
2015; Santos et al., 2012). The adipose tissue, besides being one of the main tissues for the 76 
occurrence of lipogenesis and where the excess of fatty acids are stored in the form of 77 
triglycerides (Kersten, 2001; Lyssimachou et al., 2015; Moseti et al., 2016; Santos et al., 78 
2012), functions also as an endocrine and immune organ (Bašić et al., 2012; Birsoy et al., 79 
2013; Santos et al., 2012). 80 
Members of the peroxisome proliferator-activated receptors (PPARs), transcription factors 81 
from the NR superfamily play essential roles in adipocyte differentiation and energy 82 
homeostasis, forming obligate heterodimers with the retinoid X receptor (RXR) which 83 
changes the transcription of target genes upon the binding of a ligand to the ligand binding 84 
domain (LBD) (Janesick and Blumberg, 2011; Santos et al., 2018, 2012; Yoon, 2009). Each 85 
subtype possesses different ligand specificity, tissue distributions and biological functions 86 
(Santos et al., 2012; Yoon, 2009). 87 
Widely known as the “Master regulator of adipogenesis”, due to its absolute requirement 88 
for the process, PPARγ is mostly expressed in adipocytes and directly induces genes that 89 
regulate the adipogenic cascade, glucose uptake, lipid uptake, synthesis and storage (Birsoy 90 
et al., 2013; Janesick and Blumberg, 2011; Lyssimachou et al., 2015; Moseti et al., 2016; 91 
Santos et al., 2012). As its ligand-binding pocket is large enough to accept a variety of 92 
chemical structures, this NR is particularly sensitive to environmental chemicals (Capitão et 93 
al., 2018; Janesick and Blumberg, 2011; Lyssimachou et al., 2015) and since the 94 
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RXR:PPARγ heterodimer is permissive, either receptor pocket can be targeted by ligands 95 
and mediate its signaling (Grün & Blumberg, 2009). Moreover, PPARs occur in vertebrate 96 
and some non-vertebrate groups (Cephalochordates, Urochordates, Molluscs and 97 
Echinoderms) and RXRs in most metazoans, indicating a wide taxonomic scope of the 98 
inappropriate regulation of these pathways (Lyssimachou et al., 2015; Santos et al., 2012). 99 
Moreover, RXR is the heterodimeric partner of several other nuclear receptors that are 100 
involved in lipid homeostasis to some extent [e.g. Liver X Receptor (LXR) and Farnesoid X 101 
Receptor] and also form permissive heterodimers (Capitão et al., 2017). 102 
Obesogens are a class of EDCs capable of interfering with the lipid metabolic pathways 103 
either directly, through interaction with NR leading to changes in patterns of gene 104 
expression stimulating adipogenesis and fat accumulation, or indirectly by mimicking or 105 
blocking the action of natural hormones and regulating appetite and satiety (Grün and 106 
Blumberg, 2007; Janesick and Blumberg, 2011; Lyssimachou et al., 2015; Newbold et al., 107 
2007). Yet, several other chemicals may affect lipid homeostasis through mechanisms that 108 
do not lead to lipid accumulation (Coimbra et al. 2015; Capitão et al., 2017). Natural or 109 
xenobiotics, these chemicals are widely used in everyday products (e.g. food packages, 110 
medical devices, toys, cosmetics) (Janesick & Blumberg, 2011), from which they might 111 
leach promoting their ubiquitous presence in the environment and threatening not only 112 
human populations worldwide, but also the ecosystems (Capitão et al., 2017).  113 
The exact MoA of some of these chemicals has not yet been determined, as they may act on 114 
the several distinct levels aforementioned. Exposure to lipid homeostasis regulators in utero 115 
and during early development can alter developmental programming leading to obesity later 116 
in life (Bašić et al., 2012; Grün and Blumberg, 2007; Newbold et al., 2007; Santos et al., 117 
2012), as evidenced by mesenchymal stem cells (MSC) with fates biased towards the 118 
adipogenic lineage following exposure (Chamorro-Garcia & Blumberg, 2014). Other 119 
possible MoA include epigenetic modifications which could modify the expression of genes 120 
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(Bašić et al., 2012; Chamorro-Garcia & Blumberg, 2014; Newbold et al., 2007) and lead to 121 
an obesogenic effect at a transgenerational level (Chamorro-Garcia et al., 2017; Chamorro-122 
García and Blumberg, 2014). Post-translational modifications, reported to occur in several 123 
enzymes and transcription factors involved in lipid metabolism (Carnitine 124 
palmitoyltransferase I (Guan et al. 2016), ACC (Capitão et al., 2017; Wang et al., 2015), 125 
PPARγ (van Beekum et al., 2009), SREBP (Wang and Sul, 2013)), could affect the 126 
interactions of NRs with the transcriptional machinery and the processing, activity, stability 127 
and degradations of proteins, as well as their affinity for certain substrates (Guan et al., 128 
2016; Janesick and Blumberg, 2011; Lempradl et al., 2015; Wang and Sul, 2013). In 129 
addition to the conformational change in the receptors and induction of transcriptional 130 
activation through the binding of a ligand, nuclear receptors can also be activated or 131 
unrepressed through these post-translational modifications in the absence of ligands 132 
(Janesick & Blumberg, 2011). 133 
Amongst the 1300 chemicals identified as potential EDCs, very few have been evaluated 134 
through lipid homeostasis disruption endpoints (Capitão et al., 2017). So far, identified 135 
obesogens include members of the organotins, thiazolidinediones, phthalates, bisphenol-A 136 
and its polybrominated and polychlorinated derivatives, organochlorine pesticides, 137 
organophosphates, carbamates, solvents and heavy metals such as cadmium and lead, as 138 
well as estrogenic chemicals and phytoestrogens (Biemann et al., 2014; Grün and 139 
Blumberg, 2007; Janer et al., 2007; Janesick and Blumberg, 2011; Jordão et al., 2015, 2016 140 
Newbold et al., 2007; Riu et al., 2014, 2011; Santos et al., 2012; Watt and Schlezinger, 141 
2015), but in addition to the lack of information regarding their MoA, data concerning their 142 
interactions in mixtures, as they are found in the environment, is scarce (Biemann et al. 143 
2014; Capitão et al., 2017). 144 
The overall aim of this study was to evaluate the effects of complex environmental samples 145 
from a waste water treatment plant (WWTP) on lipid accumulation in zebrafish larvae. As a 146 
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proxy to better understand the underlying MoA of this complex samples, primary 147 
approaches were also conducted using transactivation assays with PPARγ/RXRα, alongside 148 
with the determination of expression of key lipogenic and adipogenic genes in zebrafish 149 
larvae. 150 
2. METHODOLOGY 151 
2.1. In vivo assay 152 
2.1.1. Species selection 153 
The zebrafish (Danio rerio), a freshwater cyprinid in the Actinopterygii class, is an 154 
emerging model for the study of lipid metabolism and metabolic diseases (Hölttä-Vuori et 155 
al., 2010; Landgraf et al., 2017). Besides the widely known advantages of this species (e.g. 156 
small size, known ideal growth conditions, large number of eggs, short life cycle), it shows 157 
a high conservation of genes, NRs and molecular processes regulating energy homeostasis 158 
between mammals and teleosts and the ability to develop metabolic diseases also reported 159 
in humans (e.g. hepatic steatosis) (Birsoy et al., 2013; Hill et al., 2005; Hölttä-Vuori et al., 160 
2010; Landgraf et al., 2017; Lyssimachou et al., 2015). Studying altered gene expression in 161 
response to toxic insults by real-time PCR (qPCR) or genomic screens is facilitated since 162 
the zebrafish genome is completely sequenced (Hill et al., 2005; Veldman and Lin, 2008). 163 
Another advantage is its optical clarity which allows the screening of lipid accumulations 164 
using staining techniques with fluorescent dyes in small larvae without dissecting them. 165 
2.1.2. Animal breeding 166 
All experiments with living fish were conducted in the facilities of BOGA (Biotério dos 167 
Organismos Aquáticos – CIIMAR) and have been approved by the CIIMAR ethical 168 
committee and by CIIMAR Managing Animal Welfare Body (ORBEA) according to the 169 
European Union Directive 2010/63/EU. 170 
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A breeding stock of adult wild-type zebrafish (Danio rerio; Singapore) was kept in a 250L 171 
aquarium with dechlorinated aerated water (28 ± 1°C), under a photoperiod of 14:10h 172 
(light:dark). The fish were fed with commercial diet Tetramin (Tetra, Germany) twice a 173 
day. Nine females and nine males were placed in cages within a 30L aquarium, the cages 174 
possessing a net bottom covered with glass marbles, preventing eggs from being consumed 175 
by adults. 176 
In the following morning, fertilized eggs were collected, cleaned and randomly allocated to 177 
different experimental aquaria. 178 
2.1.3. Test conditions 179 
The embryos obtained by natural mating were raised in 3L aquaria with dechlorinated water 180 
(28 ± 1 °C) with a 14L:10D photoperiod. Each aquarium contained 80 eggs.  181 
From hatching, 4th day post-fertilization (dpf) until the end of the experiment (18th dpf), the 182 
larvae were exposed to six different treatments in duplicate: experimental control, solvent 183 
control (0.0002% dimethylsulfoxide, DMSO), tributyltin (TBT) at 100 ng/L Sn and 200 184 
ng/L Sn (positive control), and wastewater treatment plant influent at 1.25% and 2.5%. TBT 185 
was selected as a positive control given that Lyssimachou et al., (2015) previously 186 
demonstrated massive fat accumulation in zebrafish following a life-cycle exposure to 187 
environmentally relevant concentrations. TBT test solutions were obtained by successive 188 
dilutions of a stock solution containing TBT chloride (96%, Sigma-Aldrich) in DMSO 189 
(99.9%, Sigma-Aldrich). All aquaria had the same DMSO concentration with exception of 190 
experimental control. The 24-h composite WWTP influent was obtained at the Porto 191 
municipal waste water treatment plant facility in 2017, between 3 and 9 of May, 192 
encompassing a full week from Wednesday to Tuesday. Samples were collected daily for 193 
seven consecutive days, frozen immediately after collection to prevent degradation of the 194 
compounds and used within 1 month for the assays, following a similar sampling design of 195 
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that described by González-Mariño et al., (2017) and Gracia-Lor et al., (2017). This WWTP 196 
serves a population of approximately 150.000 people (mean flux of 33000 m3/day) 197 
(González-Mariño et al., 2017; Gracia-Lor et al., 2017). The samples were characterized 198 
upon collection (mean pH= 7,03; T= 21ºC; Ammonium (mg/L) 47,8). A preliminary 199 
characterization of the composite influent was performed by Liquid Chromatography 200 
Quadrupole Time-of-flight Tandem Mass Spectrometry (LC-QTOF-MS/MS) with a 201 
particular focus on putative PPAR/RXR agonists as detailed in the Supporting Information 202 
Table S1 (Appendix A). Detected compounds were classified in confirmatory levels as 203 
proposed by (Schymanski et al., 2014).    204 
The medium was renewed daily, ammonia levels checked weekly using Palintest tablets and 205 
Palintest Photometer 7000se (0.3625 ± 0.033 mg/L N and 0.4375 ± 0.0369 mg/L N for the 206 
1.25% and 2.5% WWTP influent, respectively, and 0.1425 ± 0.0347 mg/L N for all 207 
remaining treatments), while the temperature was monitored daily. Values of mortality were 208 
registered daily and the dead larvae/eggs were removed. Total mortality did not differ 209 
among groups (data not shown) and was maintained below 20% up to the end of the assays, 210 
which is within the normal range of the species in laboratory assays (Coimbra et al., 2015). 211 
A light aeration was introduced to the aquaria on the 11th dpf. 212 
Throughout the whole experiment, care was taken in order to avoid the suffering and 213 
distress of the animals. 214 
2.1.4. Feeding protocol 215 
From 5 to 14 dpf larvae were fed with a standard diet (SD), Gemma Micro (Skretting), 216 
supplemented with cod liver oil (Fagron) to obtain a final lipid content of 25% dry matter. 217 
Artemia spp. cysts (Brine Shrimp Eggs; Ocean Nutrition) put to hatch for 16 hours were 218 
supplied every other day from 7 to 13 dpf (0.2 grams fed 3 aquaria). From the 15th to the 219 
16th dpf, larvae were fed lyophilized chicken egg yolk as a high fat diet (HFD), followed by 220 
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one day of starvation prior to the analysis on the 18th dpf. The specifications of the feeding 221 
regime are summarized in table 1. 222 
Table 1. Feeding regime throughout the assay. 223 
   Period (dpf)  
 0 to 4 5 to 11 12 to 14 15 to 16 17 to 18 











Quantities None 12 mg x3 24 mg (100-
200 µm x2; 
200-400 µm 
x1) 






2.1.5. Nile Red staining 225 
On the 18th dpf, 7 larvae of similar size (6.55 ± 0.56 mm) were selected per aquarium 226 
and individually incubated with Nile Red (Sigma-Aldrich) (stock of 5 mg/mL in acetone 227 
diluted 1:1000 in dechlorinated water) in 3mL-wells plates, for 60 minutes, at 28 °C in the 228 
dark. The larvae were rinsed twice with dechlorinated water and anesthetized during 30 229 
seconds with Tricaine 1000mg/g (Pharmaq) (stock of 168 mg/mL diluted 1:1000 in 230 
dechlorinated water). 231 
The larvae were analyzed in water within approximately 2 minutes, under the 232 
microscope Nikon Eclipse TS100 with fluorescence filter B-2A: EX: 450-490nm, BA: 233 
520nm. All images were captured under the same settings with imaging software NIS-234 
Elements D (version 4.13). Fluorescence signals were determined using ImageJ software 235 
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(National Institutes of Health), by converting the images into 8-bit grayscales, measuring 236 
the background fluorescence, and subtracting to the value of larvae fluorescence obtained 237 
by selecting the white adipose tissue (WAT) and individual adipocytes in the perivisceral 238 
area (Figure 1). 239 
 240 
Figure 1. Zebrafish at the 18th dpf colored with Nile Red dye; A: Perivisceral area 241 
containing the analyzed WAT and individual adipocytes; B: Example of area for 242 
background fluorescence (note: image not converted to 8-bit grayscales). 243 
The remaining zebrafish were euthanized in Ethyl 3-aminobenzoate methanesulfonate 244 
(98%; Sigma-Aldrich) at 200 mg/L to guarantee minimum pain and alleviation from 245 
discomfort, according to Annex IV of the EU Directive 2010/63/EU, and were stored in 246 
RNAlater (Sigma) for posterior molecular biology determinations. 247 
2.2. Gene expression 248 
2.2.1. RNA extraction and cDNA synthesis 249 
The RNA extraction was performed for each body of larvae using illustraTM RNA spin Mini 250 
RNA Isolation kit (GE Healthcare) and the RNA quality was confirmed with 1% agarose 251 
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gel. The concentration of total RNA was determined using Gen5™ software and equipment 252 
Synergy HT Multi-Mode Plate Reader (BioTek). 253 
Total cDNA was synthesized from 200 ng of RNA using the iScriptTM cDNA Synthesis 254 
(Bio-Rad) kit and TGradient Thermocycler (Biometra). All assays were performed by 255 
following the kits’ protocols. 256 
2.2.2. Real-time PCR 257 
The expression of reference gene β-actin and target genes PPARγ, RXRα, FASn, ACOX, 258 
SREBP1, CCAAT/enhancer-binding protein α (C/EBPα) and diacylglycerol acyltransferase 259 
(DGAT2), individually, was assessed for each body of larvae separately, using Mastercycler 260 
ep realplex system (Eppendorf). Primers (Table S2) were designed with Primer-Blast-NCBI 261 
tool and synthesized by STABVIDA (Portugal). 262 
Each sample was amplified in duplicate, loaded into 96-well PCR plates containing 10 µL 263 
of reaction volume corresponding to 1 µL of cDNA (equals 10 ng), 5 µL of IQ TM SYBR® 264 
Green Supermix (Bio-Rad) and 200 nM of each primer.  265 
The two-step qPCR program was performed according to the Taq polymerase’s protocol, 266 
with a melting curve (55-95°C with 0.5°C increment) being generated at the end to confirm 267 
the specificity of each amplification. Products were also visualized through agarose gel 268 
electrophoresis, confirming the presence of single bands. The specificity of the 269 
amplification was verified by adding a “no template control” to each plate and the 270 
efficiency determined for each gene through standard curves with successive dilutions of 271 
cDNA pools from each sample (6 dilution steps with dilution factor 1:5). Efficiencies 272 
between 88-109% were considered acceptable. The reference gene was validated by its 273 
stability among the exposure groups and controls, verified through one-way ANOVA. 274 
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The relative quantification of target genes was performed according to Livak’s method 275 
(Livak & Schmittgen, 2001). Relative changes in gene expression were calculated based on 276 
the amount of target normalized to β-actin and relative to an internal calibrator:  277 
Amount of target = 2 -ΔΔCt = (2 -(Ctsample-Ctcalibrator)target ) / (2 -(Ctsample-Ctcalibrator)reference) 278 
2.3. Transactivation assays 279 
2.3.1. Plasmid constructs 280 
Primers were designed using Primer 3 to amplify the Hinge Region (HR) plus LBD of 281 
human and zebrafish RXRα and PPARγ (Table S3), with insertion of additional 282 
oligonucleotides of recognition sequences for restriction enzymes XbaI and KpnI 283 
(Promega). 284 
A rapid amplification of cDNA ends PCR was performed using zebrafish cDNA pool as a 285 
template for RXRα and zebrafish liver cDNA for PPARγ. The products were gel-purified 286 
and digested with restriction enzymes, for insertion of RXRα and PPARγ in pBIND vectors 287 
and insertion of RXRα in a pACT vector. Constructs’ integrity and correct orientation of 288 
inserts were verified through Sanger sequencing. 289 
2.3.2. Transactivation assay 290 
The characterization of RXRα, PPARγ and heterodimer responses to different compounds 291 
was attained using the CheckMate™ Mammalian Two-Hybrid System (Promega). Viable 292 
COS-1 cells (kidney, Chlorocebus sabaeus), distributed at a density of 2x105 cells/mL were 293 
grown in DMEM with phenol red (PANBiotech), supplemented with 1% 294 
Penicillin/Streptomycin (PANBiotech) and 10% fetal bovine serum (PANBiotech) for 24h 295 
at 37 °C and 5% CO2. The plasmids were transfected into the cells (confluence around 296 
80%), using lipofectamine (Invitrogen), Opti-MEM 1x (Gibco), 500 ng of pBind and pGL4, 297 
as well as 750 ng of pcDNA3 (or pACT for heterodimer assays) and incubated for 5 hours 298 
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(André et al., 2017). Zebrafish and human NRs were exposed to the treatments for 24h: 299 
DMEM without phenol-red supplemented with 1% Penicillin/Streptomycin and 10% 300 
charcoal-treated Fetal Bovine Serum (PANBiotech) was contaminated with DMSO 0.1% 301 
(solvent control; 99.9%, Sigma-Aldrich), TBT 250 nM (positive control; TBT chloride 302 
96%, Sigma-Aldrich) and 3 dilutions of WWTP influent (1.25%, 2.5%, 10%). 303 
On the following day, cells were lysed with 1x Passive Lysis Buffer (Promega) and the 304 
luciferase activity was detected using the Dual-Luciferase® Reporter Assay System 305 
(Promega). The luminescence was measured using equipment Synergy HT Multi-Mode 306 
Plate Reader (BioTek), with Gen5™ software. Three replicates were performed for each 307 
transactivation assay. 308 
2.4. Statistical analysis 309 
The statistical analysis was performed on IBM SPSS Statistics 24 software, where the 310 
homogeneity of variance of all data was confirmed using Levene’s tests, prior to analysis 311 
through one-way ANOVA. 312 
The Nile-Red fluorescence data, real-time PCR results and transactivation results were 313 
further analyzed through Fisher's Least Significant Difference (LSD) post-hoc test. 314 
When parametric assumptions were not attained, even after square-rooting or log-315 
transformating the data, the results were analyzed using non-parametric Mann-Whitney U 316 
test. 317 
In all cases, p-values lower or equal to 0.05 were considered statistically significant. 318 
3. RESULTS AND DISCUSSION 319 
3.1. Lipid accumulation  320 
Despite the conservation of several signaling pathways regulating lipid homeostasis 321 
throughout metazoans, the majority of studies on the effects of obesogens has focused on 322 
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mammalian models (Capitão et al., 2017). Hence for a better understanding of effects and 323 
possible MoA of chemicals impacting lipid homeostasis across vertebrates, this study 324 
combines in vivo assays alongside with molecular and biochemical techniques using the 325 
vertebrate model species Danio rerio. The study aimed to address two key questions: are 326 
complex environmental samples from WWTP able to induce an obesogenic response in 327 
zebrafish larvae? If so, and as a proxy to better understand the underlying molecular mode 328 
of action, does it involve the modulation of RXRα/PPARγ signaling pathways?  329 
Figure 2 displays the results from the in vivo assay presenting the lipid accumulation, 330 
analyzed through Nile-red staining. Obtained values correspond to the Integrated Density 331 
(the product of area and mean gray value), representing the fluorescence captured for each 332 
larva on ImageJ Software (Figure 1). Higher values indicate greater accumulation of lipids. 333 
 334 
 335 
Figure 2. In vivo induction of lipid accumulation analyzed by Nile Red staining after 336 
exposure to TBT and WWTP influents. TBT and WWTP influent values were expressed 337 
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as average fold changes ± SEM (N=7) of the solvent control and experimental control 338 
groups, respectively. *p < 0.05 (one-way ANOVA, followed by Fisher LSD’s test). 339 
A statistically significant increase (p < 0.05) in fluorescence was detected in larvae 340 
chronically exposed to the environmentally-relevant concentrations of 100 and 200 ng/L Sn 341 
TBT and 2.5% WWTP influent, with WAT deposits concentrating in the perivisceral area. 342 
Whereas the subcutaneous fat accumulation is considered an adaptive process, exceeding 343 
the storage capacity of this adipose depot, diverts the excess of fatty acids towards the 344 
accumulation in the visceral cavity, muscle and liver, primary locations for correlations 345 
with metabolic disorders and increased mortality (Chamorro-Garcia and Blumberg, 2014; 346 
Grün and Blumberg, 2009; Lyssimachou et al., 2015). 347 
Preliminary assays performed by our group with regular diet (Gemma Micro, 59% 348 
protein, 19% oil) did not lead to an increase in fat accumulation in TBT exposed larvae 349 
(data not shown). Hence, the assays were performed with a SD supplied with additional 350 
lipids (25% of lipid content). Tingaud-Sequeira and colleagues (2011), reared zebrafish 351 
larvae on a standard diet and separated them into two groups which were fed for a day with 352 
different diets, SD or hard-boiled egg yolk as an HFD, followed by two days of starvation. 353 
During starvation, the initial adiposity was recorded and larvae were posteriorly exposed for 354 
24h to 50 nM TBT and 1 nM rosiglitazone, with a final adiposity recording. The results 355 
indicated that HFD led to a more dramatic increase in lipid adiposity when the fishes were 356 
exposed, being more evident in the treatment with rosiglitazone in which, despite the fasting 357 
state, an increase in adiposity was obtained in the HFD group, oppositely to the smaller 358 
decrease recorded for the SD group when compared to the control. The present study 359 
corroborates previous findings of short-term exposures to higher TBT concentrations 360 
(Tingaud-Sequeira et al., 2011) and to life-cycle zebrafish exposure to 10 and 50 ng/TBT 361 
(Lyssimachou et al., 2015). Similarly, zebrafish larvae exposed for 15 days to 362 
tetrabromobisphenol A (TBBPA), tetrachlorobisphenol A, TBBPA-sulfate or TBT, and fed 363 
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with egg yolk, exhibited significant increases in lipid accumulation (Riu et al., 2014). The 364 
authors also pointed out that when the larvae were fed with regular diets, instead of HFD, 365 
none of the treatments resulted in the staining of larvae, highlighting the impact of the 366 
synergy of both calories and chemical exposure in lipid accumulation.  367 
As fat build-up results from the balance between lipogenesis and lipolysis (Kersten, 368 
2001), this study assessed the impact of TBT and the WWTP influent on both lipogenesis 369 
and adipogenesis focusing in particular in PPARγ:RXRα associated pathways 370 
(i.e.,PPARγ:RXRα, SREBP1, C/EBPα, FASn, DGAT2) and also fatty acid oxidation 371 
(ACOX1). Bodies of zebrafish larvae from the in vivo assay were analyzed by qPCR to 372 
determine whether the lipid accumulation verified in vivo was accompanied by changes in 373 
levels of mRNA of key transcription factors and enzymes ruling lipid homeostasis. 374 
Interestingly, the PCR results (Figure 3) only reveal statistically significant differences 375 
in the expression of the transcription factor SREBP1 at 100 ng/L Sn TBT and RXRα 376 
alongside DGAT2 at 200 ng/L Sn TBT, environmental concentrations that triggered 377 
significant lipid accumulations in vivo. Both the increase of SREBP1 levels at the lowest 378 
concentration and decrease of RXRα expression levels at the highest concentration, suggest 379 
a mechanism of negative feedback, whereas the overexpression of DGAT2, the enzyme that 380 
catalyzes the final reaction in triglyceride’s synthesis (Lyssimachou et al., 2015), suggests 381 
that lipid production has not ceased at the highest concentration of TBT. While the lack of 382 
altered significant gene expression for 1.25% influent matches the observed lack of lipid 383 
accumulation, the similar observation for the 2.5% concentration, which contrastingly 384 
induced significant accumulation, could also be due to a negative feedback mechanism. 385 
This could explain the 3-fold decrease in gene expression of C/EBPα in larvae exposed to 386 





Figure 3. In vivo induction of lipogenic and adipogenic genes in zebrafish, following 390 
exposure to TBT and WWTP influents. Values normalized to β-actin and relative to an 391 
internal calibrator are expressed as the average fold changes ± SEM of the solvent control 392 
and experimental control groups for TBT and the WWTP influents, respectively. *p < 0.05 393 
(one-way ANOVA, followed by Fisher LSD’s test). 394 
 Similarly, Watt and Schlezinger (2015) reported lipid accumulations in bone marrow 395 
MSCs of male 9-week-old C57BL/6J mice following exposure to PPARγ-agonists 396 
rosiglitazone, TBT and triphenyltin, with no statistical significant increases in PPARγ 397 
mRNA, although downstream target genes were up-regulated (Watt & Schlezinger, 2015). 398 
Whereas PPARγ plays an important role in lipogenesis and adipogenesis in the adipose 399 
tissue, the levels of expression in other tissues are low, for example in the liver where the 400 
main mediator of the expression of lipogenic genes is SREBP-1 (Kersten, 2001). Thus, it is 401 
not surprising that several studies report organ-specific and sex-specific effects of exposure 402 
to TBT and other lipid homeostasis regulators in a variety of model animals (Bian et al., 403 
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2017; Chamorro-García et al., 2013; Guan et al., 2016; Lyssimachou et al., 2015; Zhang et 404 
al., 2012). 405 
Nevertheless, the transcription factor SREBP1, which was overexpressed at 100 ng/L 406 
Sn TBT, is an early regulator of adipogenesis and stimulates PPARγ expression for the final 407 
adipocyte maturation where they will modulate the expression of adipogenic and lipogenic 408 
enzymes, such as ACCα and FASn (Birsoy et al., 2013; Capitão et al., 2017; Kersten, 2001; 409 
Lyssimachou et al., 201; Moseti et al., 2016; Santos et al., 2012). 410 
3.2. Transactivation assays 411 
To further address if the WWTP influent and TBT could transactivate or repress the 412 
PPARγ/RXRα signaling pathways, we have performed transactivation assays using human 413 
(Hs) and zebrafish (Dre) PPARγ and RXRα receptors, as well as with the RXRα:PPARγ 414 
heterodimer. The results indicate that both influent and TBT are able to interact with the 415 
receptors in vitro, which might possibly be one of the mechanisms underlying the observed 416 
lipid accumulation and disruption of lipid homeostasis in vivo. The organotin TBT was the 417 
first obesogen to be associated with RXR and PPARγ signaling (Janesick and Blumberg, 418 
2011; Santos et al., 2012). Indeed, our positive control TBT transactivated HsRXRα, 419 
PPARγ and heterodimer at 250 nM (Figure 4). Interestingly, the results for the zebrafish 420 
receptors (Figure 5) show a different response when compared to HsPPARγ. While 421 
DreRXRα activity was significantly induced and PPARγ not affected by TBT, the 422 





Figure 4. In vitro transactivation of Homo sapiens receptors by 250 nM TBT and WWTP 426 
influent. The activity of firefly luciferase (Photinus pyralis) was normalized to the activity 427 
of Renilla luciferase (Renilla reniformis) and then expressed as average fold changes ± SEM 428 





Figure 5. In vitro transactivation of Danio rerio receptors by 250 nM TBT and WWTP 432 
influent. The activity of firefly luciferase (Photinus pyralis) was normalized to the activity 433 
of Renilla luciferase (Renilla reniformis) and then expressed as average fold changes ± SEM 434 
of the solvent control group. *p < 0.05 (one-way ANOVA, followed by Fisher’s LSD test). 435 
Analyzing the amino acid sequences of human and zebrafish receptors, it was found a 436 
high percentage of similarities (99%) in both RXRα DNA-binding domain (DBD) and 437 
LBD, oppositely to the 94% similarities at the PPARγ DBD and 74% at the LBD (Ouadah-438 
Boussouf & Babin, 2016; Zhao et al., 2015), suggesting different ligand-binding affinities 439 
for PPARγ. Furthermore, the cysteine in position 285 of HsPPARγ LBD, which is mutated 440 
into a tyrosine in the zebrafish (Capitão et al., 2017), has been shown as essential for the 441 
activation of this receptor by TBT (Harada et al., 2015). This mutation could underlie the 442 
disparity between the transactivation results, as differences in nuclear receptors’ structures 443 
may lead to distinct chemical binding and activation outcomes (Capitão et al., 2017). The 444 
underlying mechanism of this finding has been recently discussed by Capitão et al., (2018). 445 
Indeed, Riu and collaborators have also noted that known HsPPARγ agonists 446 
thiazolidinediones (rosiglitazone, pioglitazone, ciglitazone and troglitazone), TBT and a 447 
prostaglandin could not be used as positive controls in assays involving DrePPARγ, as they 448 
failed to activate the receptor in vitro (Riu et al., 2014). 449 
The lack of DrePPARγ transactivation in comparison to RXRα suggest that the TBT’s 450 
obesogenic effects reported here might be mediated by RXRα instead. In fact, this chemical 451 
was also reported to interact with other permissive heterodimers (LXR:RXRα heterodimer) 452 
(Capitão et al., 2017; Le Maire et al., 2009) and it has been suggested that the covalent 453 
binding to HsRXRα’s Cys432 would allow a more efficient stabilization of the active 454 
receptor conformation, than its non-covalent ionic bond to HsPPARγ’s Cys285 (Harada et 455 
al., 2015; Le Maire et al., 2009). Ouadah-Boussouf and Babin (2016) demonstrated that the 456 
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obesogenic effect of TBT on DreRXR:PPARγ was not inhibited by the HsPPARγ 457 
antagonist T0070907, but was fully abolished by the HsRXR antagonist UVI3003 and by a 458 
combination of HsRXR:RXR and HsRXR:PPARγ antagonists. The findings of  Ouadah-459 
Boussouf and Babin (2016) support that RXR plays a central role in TBT-modulated 460 
obesogenic outcomes and that in vivo obesogenic effects might occur through RXR-461 
dependent pathways which do not necessarily involve PPAR isoforms (Ouadah-Boussouf & 462 
Babin, 2016). 463 
TBT may modulate other NRs involved in lipid homeostasis such as LXR:RXR 464 
heterodimer (Capitão et al., 2017; Le Maire et al., 2009). Interestingly, LXR is tightly 465 
related to cholesterol homeostasis and regulates the expression of SREBP-1 (Capitão et al., 466 
2017), one of the upregulated target genes after exposure to TBT at 100 ng/L Sn. 467 
Regardless, unveiling the crystallographic structure of TBT binding to the human RXR and 468 
PPARγ has allowed a better understanding of the interaction with these receptors. Similar 469 
studies should be performed with other chemicals and nuclear receptors to help elucidate 470 
the different species-responses to a particular lipid homeostasis regulator.  471 
Regarding the environmental samples, only the highest tested influent concentration (10%) 472 
was able to significantly transactivate the heterodimer HsPPARγ/RXRα, thus indicating the 473 
presence in the influent of HsPPARγ/RXRα agonists (Figure 4). It is important to have in 474 
mind that the tested concentrations of 1.25% and 2.5% were used when zebrafish larvae 475 
were chronically exposed from the 4th to the 18th dpf in vivo. Thus, the results are not easily 476 
comparable, as transactivation assays comprise a short 24-hour window of exposure, which 477 
could explain the lack of transactivation at these lower concentrations. In DrePPARγ a 1.5-478 
fold induction was observed for the 10% influent concentrations, although differences did 479 
reach significance in comparison with control (p = 0.089).  480 
A simultaneous exposure to a “cocktail” of chemicals can potentially lead to additive or 481 
even synergistic effects (e.g. by acting on both RXR and PPARγ simultaneously) (Biemann 482 
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et al., 2014; Riu et al., 2011) but also to antagonistic effects. Since several compounds have 483 
also been shown to repress the transactivation of nuclear receptors involved in lipid 484 
homeostasis, the possibility of antagonistic actions of different chemicals on the nuclear 485 
receptors cannot be disregarded (Biemann et al., 2014). Indeed, the chemical 486 
characterization of the influent used in this study (Appendix A, Table S1) shows the 487 
presence of a variety of chemicals that have been reported to impact lipid homeostasis 488 
triggering lipid storage, i.e., (diclofenac (Puhl et al., 2015), ibuprofen (Puhl et al., 2015), 489 
dibutyl phthalate (Mjaeed et al., 2017), methyl paraben (Hu et al., 2016), acesulfame (Bian 490 
et al., 2017), saccharin (Suez et al., 2015)) or lipid mobilization, i.e., (metformin (Park et 491 
al., 2009), piperine (Shah et al., 2011), irbesartan (Parhofer et al., 2007), valsartan (Cole et 492 
al., 2010), chenodiol (Chen et al., 2017), hippuric acid (Zhao et al., 2016), fenofibric acid 493 
(Alagona, 2010)). Some of the compounds present in the influent have been reported to 494 
interact with the PPAR/RXR receptors, either through induction and/or agonism [PPARγ: 495 
acesulfame (Simon et al., 2013), saccharin (Simon et al., 2013), irbesartan (Afzal et al., 496 
2016), valsartan (Hasan et al., 2014; Storka et al., 2008), diclofenac (Ayoub et al., 2009; 497 
Puhl et al., 2015), ibuprofen (Puhl et al., 2015), dibutyl phthalate (Lapinskas et al., 2005; 498 
Pereira-Fernandes et al., 2013), metformin (Elia et al., 2011); methyl paraben (Pereira-499 
Fernandes et al., 2013); PPARα: metformin (Maida et al., 2011); dibutyl phthalate 500 
(Lapinskas et al., 2005), irbesartan (Rong et al., 2010); fenofibric acid (Qiu et al., 2017); 501 
Mouse PPARα: triclosan (Wu et al., 2014);] or suppression and/or antagonism [PPARγ: 502 
piperine (Park et al., 2012); PPARα: chenodiol (Chen et al., 2017); human PPARα: 503 
triclosan (Wu et al., 2014)]. 504 
The preliminary mechanistic approach performed here to address the involvement of the 505 
PPARγ/ RXRα in the lipid accumulation observed in vivo in the 2.5% influent exposed 506 
larvae is not fully conclusive. Even though the chemical analysis of our environmental 507 
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samples confirms the presence of known PPARγ agonists and antagonists, it seems likely 508 
that other mechanisms might have also directed the in vivo effects observed. 509 
So far, very few studies reported the impact of chemical mixtures and environmental 510 
samples on obesity and metabolic endpoints (Adeogun et al., 2016; Biemann et al., 2014; 511 
Lyche et al., 2013, 2011; Maisano et al., 2016), which is concerning, as only the exposure 512 
to mixtures depict real-case scenarios and the results are not always predictable by the 513 
effects of the individual compounds alone (Biemann et al., 2014; Rodrigues et al., 2006; 514 
Santos et al., 2006, 2008; Sarria et al., 2011). In addition to organotins, other groups of 515 
compounds have been investigated for their variety of MoA on obesity outcomes and lipid 516 
homeostasis disruption: primary phthalates, such as (2-ethylhexyl) phthalate (DEHP), 517 
activate PPARα, favoring a lipolysis state, whereas their metabolites show preference for 518 
PPARγ (Grün & Blumberg, 2009); Halogenated Bisphenol A derivatives have been shown 519 
to disrupt the thyroid hormone receptor, estrogen receptors and the PPARγ signaling (Bašić 520 
et al., 2012; Riu et al., 2011). As lipogenesis and adipogenesis involve a complex network 521 
of transcription factors and enzymes, the disruption of the energy homeostasis can occur at 522 
many levels (Bašić et al., 2012). Weighting these different factors together, through the 523 
study of complex samples of chemicals, is important to obtain a more realistic assessment 524 
of the impact of these mixtures on animal and human health. Interestingly, epidemiological 525 
and toxicological studies show a moderate to strong probability of human obesity being 526 
associated with exposure to DDE, Di-2-ethylhexylphthalate and BPA (Trasande et al., 527 
2015). 528 
4. CONCLUSION 529 
The present study demonstrates, for the first time, obesogenic responses in zebrafish 530 
larvae following exposure to complex environmental samples reported to contain an array 531 
of chemicals known to modulate lipid homeostasis. Yet, the mechanistic studies performed 532 
here are not fully conclusive. Hence, future studies should expand the screening to 533 
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additional nuclear receptors known to be engaged in vertebrate’s lipid homeostasis and the 534 
study of pathway’s other than the ones regulated by PPARγ/RXRα. 535 
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LC-QTOF-MS analysis of the influent wastewater 
The wastewater sample was submitted to a solid-phase extraction (SPE) protocol prior to their 
analysis by Liquid Chromatography Quadrupole Time-of-flight Tandem Mass Spectrometry (LC-
QTOF-MS/MS). Thus, 100 mL of the sample were passed through two 150 mg cartridges OASIS WCX 
and OASIS WAX (Waters, Milford, MA, USA) connected in series. The cartridges were previously 
conditioned following the manufacturer’s specifications. After sample loading, the cartridges were 
dried under nitrogen stream for 20 minutes and eluted with 4 consecutive fractions consisting of 1) 
10 mL of methanol, 2) 10 mL of methanol containing 5 % of ammonia, 3) 10 mL of methanol 
containing 2% of formic acid and 4) 10 mL of ethyl acetate. All these fractions were evaporated to 
dryness and reconstituted in 100 µL of methanol. The final extracts were injected (10 µL) into a LC-
QTOF-MS 6520 system (Agilent Technologies, Santa Clara, USA). The chromatographic column was 
a Synergy Fusion-RP 100x2mm, 4µm (Phenomenex, Torrance, CA, USA) and the mobile phases 
consisted of ultrapure water (A) and methanol (B) both containing 0.1% formic acid. After the 
injection, the column was maintained at 95% A during 1 min, then, a linear gradient of 15 minutes 
was programmed from 95% A to 100% B (hold for 5 min) and the system was maintained at initial 
conditions again for other 10 min before the following injection. The QTOF-MS system worked in 
the “All Ions” acquisition mode using a collision energy of either 0 or 20 V (as to obtain the 
pseudomolecular ion and product ions), in both electrospray (ESI) positive and negative modes. 
Nitrogen was used as nebulizing (40 psi) and drying gas (300 °C, 5 L min–1) in the dual ESI source and 
also as collision gas in the MS/MS and All Ions experiments. The QTOF instrument was operated in 
the high resolution 4 GHz mode. This mode provides a full width at half-maximum (FWHM) 
resolution of ca. 10 600 at m/z 118.0862 and ca. 16 900 at m/z 922.0097. A reference calibration 
solution, supplied by Agilent, was continuously sprayed in the source during the chromatographic 
run, providing the required accuracy of mass assignations, according to the manufacturer 
instructions. 
The MS data treatment was made with the MassHunter B.07.01 software using the algorithm “Find 
by Formula” with fragment confirmation against the Agilent Forensic Toxicology, Veterinary Drugs, 
Pesticides and Water Pollutants Libraries, which all together contain ca. 11,000 chemicals, of which 
about 3,500 have MS/MS spectra. Tentatively identified compounds were reinjected in MS/MS 
mode at 10, 20 and 40 V collision energies for further confirmation. Blank samples of the whole 
analytical process were also processed and chemicals were only reported if they were detected in 
at least two replicate analysis of the sample and its signal was 5 times higher than the blank. 
The identified compounds are shown in Table S1, classified in confirmatory levels, according to 
Schymanski et al., 2014. Only those compounds at a high enough confirmation level (level 2b or 
higher) are reported. The presence of twelve out of 20 analytes was confirmed through their 
comparison with reference standards (Level 1), 5 analytes were confirmed by matching their 
structure with different commercial libraries (Level 2a) and finally 3 compounds were tentatively 
identified by checking the possible fragmentation pattern (Level 2b).  
Table S1. Summary of chemicals detected in the wastewater sample.  
Compound detected Level* Fórmula Rt (min) 
ESI 
mode Uses CAS 
Metformin 1 C4 H11 N5 1.8 + Hypoglicemic 657-24-9 
Paracetamol 1 C8 H9 N O2 3.5 + Analgesic 103-90-2 
Dibutylphthalate 1 C16 H22 O4 18.9 + Plasticizer 84-74-2 
Benzophenone 8 1 C14 H12 O4 16.4 + UV filter 131-53-3 
TCPP 1 C9 H18 Cl3 O4 P 17.2 + Flame retardant 13674-84-5 
Piperine 2a C17 H19 N O3 17.7 + Food additive 94-62-2 
Methyl paraben 1 C8H8O3 14.6 - Antimicrobial agent 99-76-3 
Triclosan 1 C12H7Cl3O2 18.5 - Antiseptic 3380-34-5 
Netilmicin 2b C21 H41 N5 O7 12.6 + Antibiotic 56391-56-1 
Irbesartan 1 C25 H28 N6 O 16.1 + Antihypertensive 138402-11-6 
Valsartan 1 C24H29N5O3 16.9 - Antihypertensive 137862-53-4 
Diclofenac 1 C14 H11 Cl2 N O2 18.1 + Antinflammatory 15307-86-5 
Hippuric acid 2a C9 H9 N O3 4.8 + Bactericide 495-69-2 
Fenofibric acid 2a C17 H15 Cl O4 17.9 + Antihyperlipidemic 42017-89-0 
Acesulfame 1 C4H5NO4S 2.5 - Sweetener 33665-90-6 
4-Hydroxybenzoic acid 2a C7H6O3 11.3 - 
Chemical reagent / parabens 
metabolilte 99-96-7 
Chenodiol 2a C24H40O4 19.0 - Anticholesterolemic  474-25-9 
Carboxyibuprofen 2b C13H16O4 14.8 - 
Ibuprofen (NSAID) 
metabolite 15935-54-3 
Saccharin 1 C7H5NO3S 3.8 - Sweetener 128-44-9 
Canbisol 2b C24 H38 O3 19.3 + Syntetic cannabinoid 56689-43-1 
* Confirmation level according to Schymanski et al. (2014). 
 
 



























































Table S2. Primers designed to amplify the HR+LBD of the NRs. Forward primers contain the recognition sequence of XbaI; Reverse primer 
contains the sequence for KpnI. 
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